Form 4 for IOVA IOVANCE BIOTHERAPEUTICS, INC.
Accepted 2022-06-02 00:00:00 ET · period of report 2022-05-31 · accession 0001104659-22-067763 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-06-02 | 2022-05-31 | IOVA | MCPEAK MERRILL A | Dir | P - Purchase | $6.84 | +10.0K | 20.1K | +99% | +$68.4K | |
| I | 2022-06-02 | 2022-05-31 | IOVA | MCPEAK MERRILL A | Dir | P - Purchase | $6.80 | +10.0K | 218.6K | +5% | +$68.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-31 | P | A | 10,000 | $6.84 | 20,150 | D By Trust | — | — | (F1) An aggregate of 200,000 shares previously held by the reporting person were transferred as a bona fide gift earlier in 2022. (F2) These shares are held by a family trust for which the reporting person is a trustee. |
| 2 | Common | Common Stock | 2022-05-31 | P | A | 10,000 | $6.80 | 218,633 | I | — | — |